Prognostic significance of stathmin expression in correlation with metastasis and clinicopathological characteristics in human ovarian carcinoma

被引:37
作者
Wei, San-Hua [1 ]
Lin, Fang [1 ]
Wang, Xi [1 ]
Gao, Ping [1 ]
Zhang, Hui-Zhong [1 ]
机构
[1] Fourth Mil Med Univ, Tangdu Hosp, Dept Clin Diag, Xian 710038, Peoples R China
关键词
stathmin; prognostic factor; ovarian carcinoma; paraffin wax-embedded tissue; biopsies;
D O I
10.1016/j.acthis.2007.06.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Stathmin, also called oncoprotein 18, is a founding member of the family of microtubule-destabilizing proteins that play a critical rote in the regulation of mitosis. Stathmin is non-expressed in normal tissues, but stathmin gene is expressed at high levels in many human malignancies and the relationships between the levels of this gene expression in tumors and prognosis of the patients have been addressed. In this report, we explored the relationships between stathmin mRNA expression in ovarian carcinoma tissues and clinicopathological parameters. We collected and analyzed paraffin wax-embedded ovarian tumor biopsy tissues from 42 ovarian cancer patients in our hospital. We employed RT-PCR method and performed a densitometric analysis to determine the ratio of stathmin relative to beta-actin as an internal, marker. Resutts showed that the stathmin mRNA expression was detected in all the ovarian carcinoma tissue samples and those samples with metastasis had higher levels of stathmin mRNA expression in initial biopsy specimens (P<0.05). Moreover, the levels of stathmin mRNA expression between samples with and without metastasis showed a statistically significant difference (P<0.05). (C) 2007 Elsevier GmbH. All rights reserved.
引用
收藏
页码:59 / 65
页数:7
相关论文
共 27 条
[1]  
*ACOG, 1999, ACOG ED B, V250, P665
[2]  
[Anonymous], FAMILY MED PRINCIPLE
[3]   Altered levels and regulation of stathmin in paclitaxel-resistant ovarian cancer cells [J].
Balachandran, R ;
Welsh, MJ ;
Day, BW .
ONCOGENE, 2003, 22 (55) :8924-8930
[4]   Overexpression of the stathmin gene in a subset of human breast cancer [J].
Bièche, I ;
Lachkar, S ;
Becette, V ;
Cifuentes-Diaz, C ;
Sobel, A ;
Lidereau, R ;
Curmi, PA .
BRITISH JOURNAL OF CANCER, 1998, 78 (06) :701-709
[5]  
Bondy S, 2006, EUR J GYNAECOL ONCOL, V27, P585
[6]   Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors [J].
Brattsand, G .
BRITISH JOURNAL OF CANCER, 2000, 83 (03) :311-318
[7]   Prognostic value of clinical variables in ovarian cancer [J].
DiSilvestro, P ;
Peipert, JF ;
Hogan, JW ;
Granai, CO .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1997, 50 (05) :501-505
[8]  
FINKE J, 1993, BIOTECHNIQUES, V14, P448
[9]   DIFFERENTIATION-STAGE SPECIFIC EXPRESSION OF ONCOPROTEIN-18 IN HUMAN AND RAT PROSTATIC ADENOCARCINOMA [J].
FRIEDRICH, B ;
GRONBERG, H ;
LANDSTROM, M ;
GULLBERG, M ;
BERGH, A .
PROSTATE, 1995, 27 (02) :102-109
[10]  
HANASH SM, 1988, J BIOL CHEM, V263, P12813